Old Web
English
Sign In
Acemap
>
authorDetail
>
Lauren E. Cain
Lauren E. Cain
Takeda Pharmaceutical Company
Internal medicine
Oncology
Medicine
Azacitidine
exploratory analysis
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Progression-Free Survival (PFS) Benefit Demonstrated and Quality of Life (QoL) Maintained across Age and Frailty Subgroups with the Oral Proteasome Inhibitor (PI) Ixazomib Vs Placebo As Post-Induction Maintenance Therapy in Non-Transplant Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): Analysis of the TOURMALINE-MM4 Phase 3 Trial
2020
Blood
Sara Bringhen
Luděk Pour
Reuben Benjamin
Sebastian Grosicki
Chang-Ki Min
Danielle Leão Cordeiro de Farias
Alexander Vorog
Richard Labotka
Bingxia Wang
Dasha Cherepanov
Lauren E. Cain
Sudhakar Manne
S. Vincent Rajkumar
Meletios A. Dimopoulos
Show All
Source
Cite
Save
Citations (1)
Randomized Phase 2 Trial of Pevonedistat Plus Azacitidine Versus Azacitidine in Higher-Risk Myelodysplastic Syndromes/Chronic Myelomonocytic Leukemia or Low-Blast Acute Myeloid Leukemia: Exploratory Analysis of Patient-Reported Outcomes
2020
Blood
Joshua F. Zeidner
Flora Mazerolle
Jill A Bell
Lauren E. Cain
Douglas V. Faller
Mehul Dalal
Antoine Regnault
Robert J. Fram
Show All
Source
Cite
Save
Citations (0)
1